drugset / Trial / NCT06423859

Articaine Plus Dexmedetomidine in Supraclavicular Block

NCT06423859

Unknown 66 enrolled Benha University
RandomizedParallel-groupTriple-blindTreatment

Summary

Articaine has emerged as a local anesthetic (LA) that produces sensory and motor blockade shorter than bupivacaine and lower in neurotoxicity than lidocaine. Studies have shown that adding dexmedetomidine to LA produces prolongation of sensory and motor bock duration. Early regain of motor power with adequate analgesia is needed in ambulatory surgery, for early start of physiotherapy. This study was designed to test efficacy of adding dexmedetomidine to articaine on the duration of sensory and motor block.

Timeline

Start
2024-02-01
Primary completion
2024-08-01
Completion
2024-08-20

Drugs

EvaluationDrugModalityDoseRoute
Subject Articaine Other / unclassified 2 % Other
Subject Dexmedetomidine Other / unclassified 1 ug/kg Other

Indications

No indication recorded.